2024-10-22 07:57:47
Fifty percent recruitment milestone for PROPELLER prostate cancer trial
Corporate/ 2023-07-23
Fifty percent recruitment milestone for ...

SYDNEY,Dec. 1,2021-- Clarity Pharmaceuticals(ASX: CU6) ("Clarity"),a clinical-stage radiopharmaceutical company developing next-ge...

TOT BIOPHARM Announces NMPA Granted Marketing Approval for Pusintin® (TAB008, Bevacizumab Injection) in China
Corporate/ 2023-07-23
TOT BIOPHARM Announces NMPA Granted Mark...

SUZHOU,China,Dec. 2,2021-- TOT BIOPHARM International Company Limited (TOT BIOPHARM,1875.HK)announced its self-developed Pusintin® (TAB0...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release